Impact of apremilast on quality of life in Behçet’s syndrome: analysis of the phase 3 RELIEF study

OBJECTIVE: To assess apremilast’s impact on patient quality of life (QoL) in active Behçet’s syndrome and correlations between improvement in patients’ QoL and efficacy measures in the phase 3 RELIEF study. METHODS: QoL measures included Behçet’s Disease QoL (BDQoL), 36-Item Short-Form Health Survey...

Descripción completa

Detalles Bibliográficos
Autores principales: Hatemi, Gülen, Mahr, Alfred, Takeno, Mitsuhiro, Kim, Doyoung, Melikoğlu, Melike, Cheng, Sue, McCue, Shannon, Paris, Maria, Chen, Mindy, Yazici, Yusuf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Vasculitis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263903/
https://www.ncbi.nlm.nih.gov/pubmed/35798511
http://dx.doi.org/10.1136/rmdopen-2022-002235

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263903/
https://www.ncbi.nlm.nih.gov/pubmed/35798511
http://dx.doi.org/10.1136/rmdopen-2022-002235

Ejemplares similares